← Back|MRKMerck & Co., Inc.
140.61 USD-3.2%Healthcare
About the company

Merck is a research-driven pharmaceutical company with deep roots in oncology, vaccines and infectious disease. Its immunotherapy franchise transformed cancer treatment and the company's finances, while Gardasil protects against HPV-related cancers worldwide. An animal health division adds steady, less cyclical revenue. Merck spends heavily on research and licensing deals to refill its pipeline, a constant necessity in an industry where every blockbuster eventually loses patent protection. The US company traces its history to 1891.

Overall
3.4
Market Cap
$346.9B
P/E (ttm)
113.4
Analyst Target
159.76 USD
+13.6%
Data as of 11:13 ·